Literature DB >> 4141224

The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

I Y Adamson, D H Bowden.   

Abstract

Administration of 0.5 mg bleomycin to mice twice weekly for 4 weeks induced pulmonary fibrosis. The initial site of injury was the intima of pulmonary arteries and veins where endothelial cells became edematous and were separated from the underlying basement membrane by large blebs. These lesions occurred after 2 weeks and were associated with infiltration of perivascular spaces by lymphocytes and plasma cells. Capillary endothelial blebbing and interstitial edema were observed after 4 weeks, when multifocal necrosis of type 1 alveolar epithelial cells was accompanied by fibrinous exudation into the alveoli. The process of repair was characterized by proliferation and metaplasia of type 2 epithelial cells, fibroblastic organization of alveolar fibrin and fibrosis of the interstitium within 8 to 12 weeks. The consistent induction of changes similar to those of diffuse pulmonary fibrosis or fibrosing alveolitis in man suggests that bleomycin-induced injury may provide a suitable model for the investigation of this ill-defined group of diseases.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4141224      PMCID: PMC1910906     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Bleomycin pulmonary toxicity.

Authors:  R A Rudders; G T Hensley
Journal:  Chest       Date:  1973-04       Impact factor: 9.410

2.  Pulmonary toxicity due to bleomycin. Report of a case.

Authors:  H F Krous; W B Hamlin
Journal:  Arch Pathol       Date:  1973-06

3.  Bleomycin-induced interstitial pneumonia in dogs.

Authors:  R W Fleischman; J R Baker; G R Thompson; U H Schaeppi; V R Illievski; D A Cooney; R D Davis
Journal:  Thorax       Date:  1971-11       Impact factor: 9.139

4.  Reparative changes following pulmonary cell injury. Ultrastructural, cytodynamic, and surfactant studies in mice after oxygen exposure.

Authors:  D H Bowden; Y R Adamson
Journal:  Arch Pathol       Date:  1971-10

5.  Ultrastructural changes in the alveolar epithelium in response to Freund's adjuvant.

Authors:  C S Faulkner; J R Esterly
Journal:  Am J Pathol       Date:  1971-09       Impact factor: 4.307

6.  Studies on bleomycin.

Authors:  H Umezawa; M Ishizuka; K Maeda; T Takeuchi
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

7.  Oxygen poisoning in mice. Ultrastructural and surfactant studies during exposure and recovery.

Authors:  I Y Adamson; D H Bowden; J P Wyatt
Journal:  Arch Pathol       Date:  1970-11

8.  New antibiotics, bleomycin A and B.

Authors:  H Umezawa; K Maeda; T Takeuchi; Y Okami
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

9.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis.

Authors:  J G Scadding; K F Hinson
Journal:  Thorax       Date:  1967-07       Impact factor: 9.139

10.  Renewal of alveolar epithelium in the rat following exposure to NO2.

Authors:  M J Evans; L J Cabral; R J Stephens; G Freeman
Journal:  Am J Pathol       Date:  1973-02       Impact factor: 4.307

View more
  149 in total

1.  Continuous secretion of monocyte chemotactic factors and fibroblast growth factors by alveolar macrophages following a single exposure to bleomycin in vitro.

Authors:  E M Denholm
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

Review 2.  Pulmonary epithelial stem cells.

Authors:  A E Bishop
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

3.  Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells.

Authors:  Sarah J Ohle; Asha Anandaiah; Attila J Fabian; Alan Fine; Darrell N Kotton
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

4.  Conditional depletion of airway progenitor cells induces peribronchiolar fibrosis.

Authors:  Anne-Karina T Perl; Dieter Riethmacher; Jeffrey A Whitsett
Journal:  Am J Respir Crit Care Med       Date:  2010-09-24       Impact factor: 21.405

5.  Role of E-selectin in bleomycin induced lung fibrosis in mice.

Authors:  A Azuma; S Takahashi; M Nose; K Araki; M Araki; T Takahashi; M Hirose; H Kawashima; M Miyasaka; S Kudoh
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

Review 6.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 7.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

8.  Neonatal hyperoxia increases sensitivity of adult mice to bleomycin-induced lung fibrosis.

Authors:  Min Yee; Bradley W Buczynski; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-20       Impact factor: 6.914

9.  [The so-called shock lung, a disease of lung parenchyma (author's transl)].

Authors:  P von Wichert; K Riesner
Journal:  Langenbecks Arch Chir       Date:  1977-12-14

10.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3.

Authors:  Dianhua Jiang; Jiurong Liang; Jennifer Hodge; Bao Lu; Zhou Zhu; Shuang Yu; Juan Fan; Yunfei Gao; Zhinan Yin; Robert Homer; Craig Gerard; Paul W Noble
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.